Stephen Marcus

Company: Cantex Pharmaceuticals

Job title: Chief Executive Officer

Seminars:

Navigating the Regulatory Landscape for Glioblastoma: Discussing Insights into Successful Strategies for Gaining Approval in Challenging & Complex Disease Spaces such as GBM 8:30 am

Hurdles in gaining approval: Discuss difficulties in regulatory approval for GBM therapies due to the complexity of the disease Navigating the regulatory process: Highlighting effective approaches for navigating the regulatory process in GBM, including clinical trial design and data requirements Explore the role of collaboration: Highlighting the importance of relationships between biotech companies, regulatory agencies,…Read more

day: Workshops A & B